In 2022, Chris Smith earned $2.86M in total compensation at NeoGenomics, including $1.00M salary and $1.85M bonus. Most recently acquired 2,248 shares in Jun 2023. Currently holds stock worth $7.84M. Led NeoGenomics as CEO for 2 years.
Compensation History
Annual executive compensation data for Chris Smith, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$2.86M
Salary
$1.00M
Bonus
$1.85M
Other
$12.11K
Salary
$1.00MBoard Justification
The compensation philosophy is focused on attracting, retaining, and motivating highly skilled management, with a strong emphasis on pay-for-performance.
Bonus
$1.85MBoard Justification
The bonus was based on performance metrics including revenue and adjusted EBITDA, with a corporate performance score of 98% of target, reflecting individual performance and company performance.
Other Compensation
$12.11KBoard Justification
Other compensation includes a relocation benefit and retirement plan contributions.
Restricted Stock
Board Justification
No stock vested in 2022 as the focus was on the bonus and salary components for the year.
Performance Metrics
Performance metrics included revenue growth, adjusted EBITDA, and strategic critical success factors.
Chris Smith
Ex-CEO of NeoGenomics
Education
Bachelor of Science degree from Texas A&M University
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
January 1, 1963 - 62 years ago
CEO of NeoGenomics for
2 years 7 months (Aug 2022 - Apr 2025)
Previous Experience
CEO of Ortho Clinical Diagnostics from 2019 to May 2022; key executive leadership positions at Cochlear Limited; CEO in residence at Warburg Pincus; Global Group President at Gyrus Group Plc; various leadership roles at Abbott, KCI, Prism, and Cardinal Health.
Other NeoGenomics CEOs
Holdings
Track Chris Smith's stock holdings and portfolio value over time.
Insider Trading
Chris Smith's recent stock transactions, purchases, and sales filed with the SEC.
2,248 shares
QDEL
Jun 6, 2023
Received
602,219 shares
NEO
Aug 15, 2022
Received
34,554 shares
QDEL
May 27, 2022
Received
34,554 shares
QDEL
May 27, 2022
Received
Rivals
Compare Chris Smith with competitor CEOs and industry peers.